Source: International Congress 2014 – Ceremony for the ERS Idiopathic Pulmonary Fibrosis Research Award 2014 - Hot Topic: "Understanding and treating idiopathic pulmonary fibrosis (IPF) in the 21st century"
Disease area: Interstitial lung diseases



Rating:

Share or cite this content

Citations should be made in the following way:
J. Behr (Munich, Germany). Managing IPF: connecting the dots. International Congress 2014 – Ceremony for the ERS Idiopathic Pulmonary Fibrosis Research Award 2014 - Hot Topic: "Understanding and treating idiopathic pulmonary fibrosis (IPF) in the 21st century"

Member's Comments

No comment yet.

Related content which might interest you: Healthy diet, lung, and cardiovascular health: connecting the dots Source: International Congress 2016 – Nutrition and respiratory health Year: 2016 COPD Comorbidity Network: Connecting the dots Source: Annual Congress 2013 –Highlights in epidemiology of respiratory disease Year: 2013 Connecting the dots: the role of connexins in the pulmonary vascular response to hypoxia Source: Eur Respir J, 57 (3) 2004573; 10.1183/13993003.04573-2020 Year: 2021 ABPA screening in bronchiectasis: is there a grey zone? Source: International Congress 2018 – Improving the quality of life of patients with bronchiectasis Year: 2018 Why is COPD phenotyping like sorting diamonds? Source: Eur Respir J 2014; 44: 277-279 Year: 2014 Interstitial lung disease (ILD) and multicompartment assessment of CTD: where should the respiratory physician begin? Source: Virtual Congress 2020 – Rheumatology: understanding connective tissue disease in patients with interstitial lung disease Year: 2020 Red blood cell distribution width in patients with chronic obstructive lung disease:how is changed in exacerbation? Source: International Congress 2017 – Airway disease and exacerbations Year: 2017 Targeting interleukin-13 in idiopathic pulmonary fibrosis: from promising path to dead end Source: Eur Respir J, 52 (6) 1802111; 10.1183/13993003.02111-2018 Year: 2018 Clinical trials in idiopathic pulmonary fibrosis: a framework for moving forward Source: Eur Respir J 2013; 42: 1446-1448 Year: 2013 The overlap between bronchiectasis and chronic airway diseases: state of the art and future directions Source: Eur Respir J, 52 (3) 1800328; 10.1183/13993003.00328-2018 Year: 2018 Asthma, COPD and their overlap: coexistence or something more? Source: Eur Respir J, 58 (5) 2101329; 10.1183/13993003.01329-2021 Year: 2021 Modulator treatment for people with cystic fibrosis: moving in the right direction Source: Eur Respir Rev, 29 (155) 200051; 10.1183/16000617.0051-2020 Year: 2020 Late Breaking Abstract - Change in airway volume, measured with functional respiratory imaging (FRI), differentiates between stable and progressive idiopathic pulmonary fibrosis (IPF) Source: International Congress 2019 – Comorbidities of idiopathic pulmonary fibrosis Year: 2019 Acute exacerbations of IPF: A neglected threat in IPF ? Source: ERS webinars 2019 - Acute exacerbations of IPF Year: 2019 Chronic obstructive pulmonary disease: current burden and future projections - Supplementary material Source: Eur Respir J 2006; 27: 397-412 Year: 2006 COPD; IPF; lung cancer in same individual: Can it be called 'AJMERITES SYNDROME? Source: Annual Congress 2013 –COPD treatment and others Year: 2013 Combination therapy in idiopathic pulmonary fibrosis: the way ahead will be hard Source: Eur Respir J 2015; 45: 1208-1210 Year: 2015 Demystifying fibrotic hypersensitivity pneumonitis diagnosis: it's all about shades of grey Source: Eur Respir J, 54 (1) 1900906; 10.1183/13993003.00906-2019 Year: 2019